|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61P 17/00 | |||
| A61K 31/5395 | |||
| A61K 47/38 | |||
| A61K 47/10 | |||
| A61K 9/48 | |||
| A61K 9/20 | |||
| A61K 31/519 | |||
| C07D 487/04 |
| (11) | Patento numeris | 3107544 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15709394.9 |
| Europos patento paraiškos padavimo data | 2015-02-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/016963 |
| Data | 2015-02-20 |
| (87) | Numeris | WO 2015/127310 |
| Data | 2015-08-27 |
| (30) | Numeris | Data | Šalis |
| 201461943262 P | 2014-02-21 | US | |
| 201461946480 P | 2014-02-28 | US | |
| 201462096468 P | 2014-12-23 | US |
| (72) |
MASJEDIZADEH, Mohammad Reza, US
GOURLAY, Steven, AU
|
| (73) |
Principia Biopharma Inc.,
220 E. Grand Ave., S. San Francisco, CA 94080,
US
|
| (54) | SALTS AND SOLID FORM OF A BTK INHIBITOR |
| SALTS AND SOLID FORM OF A BTK INHIBITOR |